Patents by Inventor Chiu-Hung Chen
Chiu-Hung Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240102561Abstract: A proportional valve includes a casing and a valve trim. The casing has at least one fluid inlet, a fluid outlet, at least one first connection passageway, at least one second connection passageway and an accommodating space. The first connection passageway is connected with the fluid inlet. The second connection passageway is connected with the fluid outlet. The valve trim is located in the accommodating space, including a flow splitter an adjusting rotor. The flow splitter has at least one third connection passageway and at least one fourth connection passageway. The third connection passageway is connected with the first connection passageway. The fourth connection passageway is connected with the second connection passageway. The adjusting rotor has a channel and at least one blocking portion. The adjusting rotor is rotatably disposed on the flow splitter so that the blocking portion blocks a part of the third connection passageway.Type: ApplicationFiled: November 3, 2022Publication date: March 28, 2024Applicant: COOLER MASTER CO., LTD.Inventors: Chiu Yu YEH, Wen-Hsien LIN, Wen-Hung CHEN
-
Patent number: 10105357Abstract: A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of an antibiotic drug or a pharmaceutical acceptable salt thereof. The antibiotic drug is selected from the group consisting of an aminoglycoside antibiotic drug, an anti-fungal antibiotic drug, a Cephalosporin antibiotic drug, a ?-propionamide antibiotic drug, a chloramphenicol antibiotic drug, an erythromycin antibiotic drug, a penicillin antibiotic drug, and a tetracycline antibiotic drug.. The cancer is selected from the group consisting of lung cancer, gastrointestinal tract cancer, colorectal cancer, prostate cancer, bladder cancer, cervical cancer, breast cancer, and blood cancer.Type: GrantFiled: October 23, 2015Date of Patent: October 23, 2018Assignee: LAUNX BIOMEDICAL CO., LTD.Inventors: Chiu-Hung Chen, Show-Mei Chuang, Nai-Wan Hsiao, Ruei-Yue Liang, Xiao-Tong Tan
-
Patent number: 10098852Abstract: A method for treating a cancer includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising Monobenzone or a pharmaceutical acceptable salt thereof. The cancer is selected from pleural-related cancer, abdominal-related cancer, endocrine-related cancer, gastrointestinal tract-related cancer, osteosarcoma, and skin cancer. The pleural-related cancer is lung cancer. The abdominal-related cancer is selected from bladder cancer, cervical cancer, and kidney cancer. The endocrine-related cancer is selected from prostate cancer, breast cancer, and ovarian cancer. The gastrointestinal tract-related cancer is selected from gastric cancer, hepatic cancer, colorectal cancer, pancreatic cancer, and tongue cancer.Type: GrantFiled: October 23, 2015Date of Patent: October 16, 2018Assignee: LAUNX BIOMEDICAL CO., LTD.Inventors: Chiu-Hung Chen, Show-Mei Chuang, Tzong-Der Way, Nai-Wan Hsiao
-
Patent number: 10076508Abstract: This invention provides an antibiotic drug for inhibiting drug-resistant microorganisms. The antibiotic drug comprises Fmoc-Ala-OPfp, and not only has non-cytotoxic for normal human cell but also can inhibit drug-resistant microorganisms.Type: GrantFiled: August 3, 2016Date of Patent: September 18, 2018Assignee: Peptide Cham Biotech Co., Ltd.Inventors: Chiu-Hung Chen, Yeh Chen
-
Patent number: 10045962Abstract: Provided in the present invention are uses of duloxetine hydrochloride in preparing a pharmaceutical composition for treatment of cancer.Type: GrantFiled: April 20, 2017Date of Patent: August 14, 2018Assignee: LAUNX BIOMEDICAL CO., LTD.Inventors: Chiu-Hung Chen, Show-Mei Chuang, Tzong-Der Way, Nai-Wan Hsiao
-
Patent number: 10016390Abstract: Provided in the present invention are uses of duloxetine hydrochloride in preparing a pharmaceutical composition for treatment of cancer.Type: GrantFiled: April 20, 2017Date of Patent: July 10, 2018Assignee: LAUNX BIOMEDICAL CO., LTD.Inventors: Chiu-Hung Chen, Show-Mei Chuang, Tzong-Der Way, Nai-Wan Hsiao
-
Publication number: 20170312260Abstract: A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of Azelnidipine or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of a pleural-related cancer, an abdominal-related cancer, an endocrine-related cancer, a gastrointestinal tract-related cancer, osteosarcoma, and skin cancer.Type: ApplicationFiled: October 23, 2015Publication date: November 2, 2017Applicant: LAUNX BIOMEDICAL CO., LTD.Inventors: Chiu-Hung Chen, Show-Mei Chuang, Tzong-Der Way, Nai-Wan Hsiao
-
Publication number: 20170304387Abstract: A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of an antibiotic drug or a pharmaceutical acceptable salt thereof. The antibiotic drug is selected from the group consisting of an aminoglycoside antibiotic drug, an anti-fungal antibiotic drug, a Cephalosporin antibiotic drug, a ?-propionamide antibiotic drug, a chloramphenicol antibiotic drug, an erythromycin antibiotic drug, a penicillin antibiotic drug, and a tetracycline antibiotic drug. The cancer is selected from the group consisting of lung cancer, gastrointestinal tract cancer, colorectal cancer, prostate cancer, bladder cancer, cervical cancer, breast cancer, and blood cancer.Type: ApplicationFiled: October 23, 2015Publication date: October 26, 2017Applicant: LAUNX BIOMEDICAL CO., LTD.Inventors: Chiu-Hung Chen, Show-Mei Chuang, Nai-Wan Hsiao, Ruei-Yue Liang, Xiao-Tong Tan
-
Publication number: 20170304286Abstract: A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of Paroxetine or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of pleural-related cancer, abdominal-related cancer, endocrine-related cancer, gastrointestinal tract-related cancer, osteosarcoma, skin cancer, and blood cancer. The pleural-related cancer is lung cancer. The abdominal-related cancer is selected from bladder cancer, cervical cancer, and kidney cancer. The endocrine-related cancer is selected from prostate cancer, breast cancer, and ovarian cancer. The gastrointestinal tract-related cancer is selected from gastric cancer, hepatic cancer, colorectal cancer, pancreatic cancer, and tongue cancer.Type: ApplicationFiled: October 23, 2015Publication date: October 26, 2017Applicant: LAUNX BIOMEDICAL CO., LTD.Inventors: Chiu-Hung Chen, Show-Mei Chuang, Tzong-Der Way, Nai-Wan Hsiao
-
Publication number: 20170304228Abstract: A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of Cinacalcet HCl or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of a pleural-related cancer, an abdominal-related cancer, an endocrine-related cancer, a gastrointestinal tract-related cancer, osteosarcoma, skin cancer, and blood cancer.Type: ApplicationFiled: October 23, 2015Publication date: October 26, 2017Applicant: LAUNX BIOMEDICAL CO., LTD.Inventors: Chiu-Hung Chen, Show-Mei Chuang, Tzong-Der Way, Nai-Wan Hsiao
-
Publication number: 20170304218Abstract: A method for treating a cancer includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising Monobenzone or a pharmaceutical acceptable salt thereof. The cancer is selected from pleural-related cancer, abdominal-related cancer, endocrine-related cancer, gastrointestinal tract-related cancer, osteosarcoma, and skin cancer. The pleural-related cancer is lung cancer. The abdominal-related cancer is selected from bladder cancer, cervical cancer, and kidney cancer. The endocrine-related cancer is selected from prostate cancer, breast cancer, and ovarian cancer. The gastrointestinal tract-related cancer is selected from gastric cancer, hepatic cancer, colorectal cancer, pancreatic cancer, and tongue cancer.Type: ApplicationFiled: October 23, 2015Publication date: October 26, 2017Applicant: LAUNX BIOMEDICAL CO., LTD.Inventors: Chiu-Hung Chen, Show-Mei Chuang, Tzong-Der Way, Nai-Wan Hsiao
-
Publication number: 20170304388Abstract: A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of a cardiovascular drug or a pharmaceutical acceptable salt thereof. The cardiovascular drug is selected from the group consisting of peripheral vasodilator reaming enhancer, angiotensin converting agent inhibitor, hypotension and shock therapeutic agent, diuretic, antiarrhythmic agent, antiarralciton drug, antihypertensive agent, anticoagulant thrombolytic agent, cardiac tonic, and intravenous (hemorrhoids) therapeutic agent. The cancer is selected from the group consisting of lung cancer, intestinal cancer, colorectal cancer, prostate cancer, liver cancer, bladder cancer, cervical cancer, breast cancer, and blood cancer.Type: ApplicationFiled: October 23, 2015Publication date: October 26, 2017Applicant: LAUNX BIOMEDICAL CO., LTD.Inventors: Chiu-Hung Chen, Show-Mei Chuang, Nai-Wan Hsiao, Ruei-Yue Liang, Xiao-Tong Tan
-
Publication number: 20170216247Abstract: Provided in the present invention are uses of duloxetine hydrochloride in preparing a pharmaceutical composition for treatment of cancer.Type: ApplicationFiled: April 20, 2017Publication date: August 3, 2017Inventors: Chiu-Hung CHEN, Show-Mei CHUANG, Tzong-Der WAY, Nai-Wan HSIAO
-
Publication number: 20170035723Abstract: This invention provides an antibiotic drug for inhibiting drug-resistant microorganisms. The antibiotic drug comprises Fmoc-Ala-OPfp, and not only has non-cytotoxic for normal human cell but also can inhibit drug-resistant microorganisms.Type: ApplicationFiled: August 3, 2016Publication date: February 9, 2017Applicant: Peptide Cham Biotech Co., Ltd.Inventors: Chiu-Hung Chen, Yeh Chen
-
Publication number: 20040046096Abstract: A support apparatus. The apparatus is utilized in a semiconductor process and comprises a base, a supporting portion, and a retainer ring. The base defines a hole. The supporting portion passes through the hole and protrudes from the base. The retainer ring firmly connects the base and the supporting portion.Type: ApplicationFiled: April 8, 2003Publication date: March 11, 2004Applicant: AU Optronics Corp.Inventor: Chiu-Hung Chen